# Ezetimibe and Atorvastatin Therapy on TCFA

> **NCT02588235** · PHASE4 · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Ezetimibe and Atorvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT02588235
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02588235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02588235, "Ezetimibe and Atorvastatin Therapy on TCFA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02588235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*